The envelope glycoproteins, gp120 and gp41, of HIV (HTLV- 3/LAV) are critical components of the infectious virus, that through specific interactions with the T4 molecule on the surface of helper T lymphocytes mediate the attachment and entry of the virus. In addition, the envelope glycoprotein/T4 interaction can result in cell to cell fusion and loss of cell viability. The high specificity of target cell recognition and depletion of the T-helper subclass of lymphocytes is at least partly responsible for the immune disfunction observed in patients suffering from AIDS. In an attempt to better understand the structure of the HIV env gene product, we are proposing to define the topology of the HIV envelope glycoprotein complex through biochemical and molecular genetic approaches; to establish the organization and functional role of the long cytoplasmic domain of gp41 by construction of mutant env genes and their expression in an SV40 vector system; to engineer and express at high levels an uncleaved, secreted variant env gene product that con be obtained in sufficient amounts and purity for crystallization; to determine the 3- dimensional structure of the soluble HIV glycoprotein complex and those of the related retroviruses (STLV-3, HTLV-4); and to utilize this information for the design of antagonistic blockading reagents that might prevent gp120 binding to the T4 receptor.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Comber, R N; Friedrich, J D; Dunshee, D A et al. (1994) Alpha-(1-->2)-, and alpha-(1-->3)-, and alpha-(1-->6)-linked thioglycosidic disaccharides: syntheses and anti-HIV testing of thiokojibiose octaacetate, thionigerose, and thioisomaltose. Carbohydr Res 262:245-55
Bray, M; Prasad, S; Dubay, J W et al. (1994) A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A 91:1256-60
Johnston, P B; Dubay, J W; Hunter, E (1993) Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J Virol 67:3077-86
Srinivas, S K; Srinivas, R V; Anantharamaiah, G M et al. (1993) Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem 268:22895-9
Salzwedel, K; Johnston, P B; Roberts, S J et al. (1993) Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J Virol 67:5279-88
Hallenberger, S; Tucker, S P; Owens, R J et al. (1993) Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein. Virology 193:510-4
Cretton, E M; Xie, M Y; Goudgaon, N M et al. (1992) Catabolic disposition of 3'-azido-2',3'-dideoxyuridine in hepatocytes with evidence of azido reduction being a general catabolic pathway of 3'-azido-2',3'-dideoxynucleosides. Biochem Pharmacol 44:973-80
Dubay, J W; Roberts, S J; Hahn, B H et al. (1992) Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol 66:6616-25
Dubay, J W; Roberts, S J; Brody, B et al. (1992) Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J Virol 66:4748-56
Weidner, D A; Bridges, E G; Cretton, E M et al. (1992) Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells. Mol Pharmacol 41:252-8

Showing the most recent 10 out of 33 publications